Clinical trial
Therapeutic Approaches to HAART-Induced Lipodystrophy
NCT00461552 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00461552 |
|---|---|
| Title | Therapeutic Approaches to HAART-Induced Lipodystrophy |
| Official title | Therapeutic Approaches to HAART-Induced Lipodystrophy |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Amylin Pharmaceuticals, LLC. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy |
| Intervention type | Drug, Other |
| Interventions | Leptin, Placebo |
| Enrollment | 23 |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Apr 18, 2007 |
| Last update posted | May 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: